Here, guided by previous studies correlating structural LC integrity with cognitive reserve in older individuals, we examined the contribution of the LC – one of the first regions affected by tau pathology in AD – to cognitive resilience in preclinical AD. The gene discussed is MAPT; the disease is Alzheimer disease.